Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease

Medical Science Monitor

Volumn 13, Issue 11, 2007, Pages

  Kanazawa, Hiroshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alveolar epithelial cells; Apoptosis; Oxidative stress; Pulmonary endothelial cells; Pulmonary hypertension

Indexed keywords

VASCULOTROPIN;

APOPTOSIS; BRONCHITIS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EMPHYSEMA; HUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; REVIEW;

ENDOSTATINS; GENE EXPRESSION; HUMANS; HYPERTENSION, PULMONARY; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTIVE NITROGEN SPECIES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36148988400     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Barnes PJ, Shapiro SD, Pauwels RA: Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J, 2003; 22: 672-88
2. Demedts IK, Brusselle GG, Bracke KR et al: Matrix metalloproteinases in asthma and COPD. Curr Opin Phamacol, 2005; 5: 257-63
3. Hunninghake GW, Crystal RG: Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis, 1983; 128: 833-38
4. Repine JE, Bast A, Lankhorst I and The Oxidative Stress Study Group: Oxidative stress in chronic obstructive disease. Am J Respir Crit Care Med, 1997; 156: 341-57
5. Voelkel NF, Vandivier RW, Tuder RM: Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol, 2006; 290: L209-21
6. Ferrara N: VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol, 2000; 11: 617-24
7. Papaioannou AI, Kostikas K, Kollia P, Gourgoulianis KI: Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respir Res, 2006; 7: e128
8. Boussat S, Eddahibi S, Coste A et al: Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol, 2000; 279: L371-78
9. Yancopoulos GD, Davis S, Gale NW et al: Vascular-specific growth factors and blood vessel formation. Nature, 2000; 407: 242-48
10. Hanahan D: Signaling vascular morphogenesis and maintenance. Science, 1997; 277: 48-50
11. Zeng X, Wert SE, Federici R et al: VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn, 1998; 211: 215-27
12. Feltis BN, Wignarajah D, Zheng L et al: Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am J Respir Crit Care Med, 2006; 173: 1201-7
13. Kaner RJ, Ladetto JV, Singh R et al: Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol, 2000; 22: 657-64
14. Mura M, dos Santos CC, Stewart D et al: Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol, 2004; 97: 1605-17
15. de Boer WI, Alagappan VKT, Sharma HS: Molecular mechanisms in chronic obstructive pulmonary disease. Cell Biochem Biophys, 2007; 47: 131-47
16. Kierszniewska-Stepien D, Pietras T, Gorski P, Stepien H: Serum vascular endothelial growth factor and its receptor levels in patients with chronic obstructive pulmonary disease. Eur Cytokine Netw, 2006; 17: 75-79
17. Kasahara Y, Tuder RM, Cool CD et al: Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med, 2001; 163: 737-44
18. Kanazawa H, Asai K, Hirata K, Yoshikawa J: Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med, 2003; 114: 354-58
19. Rovina N, Papapetropoulos A, Kollintza A et al: Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in hhealthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease? Respir Res, 2007; 8: e53
20. Santos S, Peinado VI, Ramirez J et al: Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2003; 167: 1250-56
21. Liebow AA: Pulmonary emphysema with special reference to vascular change. Am Rev Respir Dis, 1959; 80: 67-93
22. Voelker NF, Cool CD: Pulmonary vascular involvement in chronic obstructive pulmonary disease. Eur Respir J, 2003; 114: S28-32
23. Gerber HP, McMurtrey A, Kowalski J et al: Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: requirement for Flk-1/KDR activation. J Biol Chem, 1998; 273: 30336-43
24. Koyama S, Sato E, Haniuda M et al: Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med, 2002; 166: 382-85
25. Kasahara Y, Tuder RM, Taraseviciene-Stewart L et al: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest, 2000; 106: 1311-19
26. Bousquet J, Jeffery PK, Busse WW et al: Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med, 2000; 161: 1720-45
27. Fujita M, Nakanishi Y: The pathogenesis of COPD: Lessons learned from in vivo animal models. Med Sci Monit, 2007; 13(2): RA19-24
28. Kanazawa H, Kurihara N, Otsuka T et al: Clinical significance of serum concentration of interleukin-8 in patients with bronchial asthma or chronic pulmonary emphysema. Respiration, 1996; 63: 236-40
29. Kanazawa H, Yoshikawa J: Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD. Chest, 2005; 128: 3191-97
30. Nagashima M, Asano G, Yoshino S: Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. J Rheumatol, 2000; 27: 2339-42
31. Dhanabal M, Volk R, Ramchandran R et al: Endostatin induces endothelial cell apotosis. J Biol Chem, 1999; 274: 11721-26
32. Yamaguchi N, Anand-Apte B, Lee M et al: Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J, 1999; 18: 414-23
33. Kanazawa H, Hirata K, Yoshikawa J: Imbalance between vascular endothelial growth factor and endostatin in emphysema. Eur Respir J, 2003; 22: 609-12
34. Van der Vliet A, Eiserich JP, Shigenaga MK et al: Reactive nitrogen species and tyrosine nitration in the respiratory tract. Am J Respir Crit Care Med, 1999; 160: 1-9
35. Corradi M, Montuschi P, Donnelly LE et al: Increased nitrosothiols in exhaled breath condensate in inflammatory airway disease. Am J Respir Crit Care Med, 2001; 163: 854-58
36. Kanazawa H, Shoji S, Yoshikawa T et al: Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease. Clin Exp Allergy, 1998; 10: 1244-50
37. Postma DS, Renkema TEJ, Noordhoek JA et al: Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymophonuclear leukocytes in chronic airflow obstruction. Am Rev Respir Dis, 1988; 137: 57-61
38. Sadeghi-Hashjin G, Folkerts G, Henricks PAJ et al: Peroxynitrite in airway disease. Clin Exp Allergy, 1998; 28: 1464-73
39. Beckman JS: Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv Pharmacol, 1995; 34: 17-43
40. Van der Vliet A, Eiserich JP, Shigenaga MK et al: Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathologic mechanism of disease? Am J Respir Crit Care Med, 1999; 160: 1-9
41. Kanazawa H, Shiraishi S, Hirata K, Yoshikawa J: Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease. Thorax, 2003; 58: 106-9
42. Galambos C, Ng YS, Ali A et al: Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am J Respir Cell Mol Biol, 2002; 27: 194-203
43. Tuder RM, Zhen L, Cho CY et al: Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol, 2003; 29: 88-97
44. Rennard I: Inflammation and repair processes in chronic obstructive lung disease. Am J Respir Crit Care Med, 1999; 160: S12-16
45. Santos S, Peinado VI, Ramirez J et al: Characterization of pulmonary vascular remodeling in smokers and patients with mild COPD. Eur Respir J, 2002; 19: 632-38
46. Voelkel NF, Tuder RM: Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J, 1995; 8: 2129-38
47. Wright JL, Lawson L, Pare PD et al: The structural and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. Am Rev Respir Dis, 1983; 128: 702-7
48. Peinado VI, Barbera JA, Abate P et al: Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1999; 159: 1605-11
49. Kanazawa H, Asai K, Nomura S: Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD. Respir Res, 2007; 8: e22
50. Kubo K, Ge Re-Li, Koizumi T et al: Pulmonary artery remodeling modifies pulmonary hypertension during exercise in severe emphysema. Respir Physiol, 2000; 120: 71-79
51. Lee CG, Link H, Baluk P et al: Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med, 2004; 10: 1095-103
52. Hoshino M: Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling. Clin Rev Allergy Immunol, 2004; 4: 267-70
53. Lee YC: The involvement of VEGF in endothelial permeability: A target for anti-inflammatory therapy. Curr Opin Invest Drugs, 2005; 6: 1124-30
54. Yano S, Matsumori Y, Ikuta K et al: Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer. Int J Clin Oncol, 2006; 11: 73-81
55. Shepherd FA, Sridhar SS: Angiogenesis inhibitors under study for the treatment of lung cancer. Lung Cancer, 2003; 41: S63-72